Kearns-Sayre syndrome
From Wikipedia, the free encyclopedia
ICD9 = | ICDO = | OMIM = 530000 | MedlinePlus = | eMedicineSubj = ped | eMedicineTopic = 2763 | MeshID = D007625 |Kearns-Sayre syndrome (abbreviated KSS) is a disease caused by a 5,000 base deletion in the mitochondrial DNA. As such, it is a rare genetic disease in that it can be heteroplasmic, that is, more than one genome can be in a cell at any given time. Unlike most mitochondrial diseases, it is not maternally inherited. Rather, it occurs sporadically.Kearnes-Sayre syndrome starts before the age of 20.
Presentation
Its expression is systemic, but many of the most common expressions are in the eyes, with ophthalmoplegia and retinal degeneration, specifically retinitis pigmentosa, common features.Other characteristic features of KSS are dysphagia, proximal weakness, hearing loss, cerebellar ataxia and cardiac conduction defects.White matter lesions are usually seen.Prognosis
There is no treatment for Kearnes-Sayre syndrome as of now.
In general, only palliative medications are available to sufferers in order to help relieve the symptoms of the disease. Eponym
It is named for Thomas Kearns and George Sayre.
Next Page
This article is based on an article from Wikipedia, the free encyclopedia and is available under the terms of GNU Free Documentation License.
In the Wikipedia there is a list with all authors of this article available.